167 related articles for article (PubMed ID: 8505850)
1. Complete variable region deletion in a mu heavy chain disease protein (ROUL). Correlation with light chain secretion.
Cogné M; Aucouturier P; Brizard A; Dreyfus B; Duarte F; Preud'homme JL
Leuk Res; 1993 Jun; 17(6):527-32. PubMed ID: 8505850
[TBL] [Abstract][Full Text] [Related]
2. Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease.
Cogné M; Bakhshi A; Korsmeyer SJ; Guglielmi P
J Immunol; 1988 Sep; 141(5):1738-44. PubMed ID: 3137264
[TBL] [Abstract][Full Text] [Related]
3. A pre-translational defect in a case of human mu heavy chain disease.
Bakhshi A; Guglielmi P; Coligan JE; Gamza F; Waldmann TA; Korsmeyer SJ
Mol Immunol; 1986 Jul; 23(7):725-32. PubMed ID: 3099178
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the 3' splice site of the leader-variable region intron of immunoglobulin heavy chain genes induces a direct splicing of leader to constant region, resulting in the production of truncated mu-chains.
Komori T; Sugiyama H
Eur J Immunogenet; 1995 Jun; 22(3):241-7. PubMed ID: 8547230
[TBL] [Abstract][Full Text] [Related]
5. Pre-B-cell development in the absence of lambda 5 in transgenic mice expressing a heavy-chain disease protein.
Corcos D; Dunda O; Butor C; Cesbron JY; Lorès P; Bucchini D; Jami J
Curr Biol; 1995 Oct; 5(10):1140-8. PubMed ID: 8548286
[TBL] [Abstract][Full Text] [Related]
6. Genomic alterations in a case of alpha heavy chain disease leading to the generation of composite exons from the JH region.
Bentaboulet M; Mihaesco E; Gendron MC; Brouet JC; Tsapis A
Eur J Immunol; 1989 Nov; 19(11):2093-8. PubMed ID: 2513209
[TBL] [Abstract][Full Text] [Related]
7. Cast nephropathy in mu heavy chain disease.
Preud'homme JL; Bauwens M; Dumont G; Goujon JM; Dreyfus B; Touchard G
Clin Nephrol; 1997 Aug; 48(2):118-21. PubMed ID: 9285150
[TBL] [Abstract][Full Text] [Related]
8. Mu heavy-chain disease--a defect in immunoglobulin assembly. Structural studies of the kappa chain.
Frangione B; Franklin EC; Prelli F
Scand J Immunol; 1976; 5(6-7):623-7. PubMed ID: 824712
[TBL] [Abstract][Full Text] [Related]
9. A DNA insertion/deletion necessitates an aberrant RNA splice accounting for a mu heavy chain disease protein.
Bakhshi A; Guglielmi P; Siebenlist U; Ravetch JV; Jensen JP; Korsmeyer SJ
Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2689-93. PubMed ID: 3085103
[TBL] [Abstract][Full Text] [Related]
10. Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition.
Cheng IK; Ho SK; Chan DT; Ng WK; Chan KW
Am J Kidney Dis; 1996 Aug; 28(2):283-8. PubMed ID: 8768927
[TBL] [Abstract][Full Text] [Related]
11. The interaction of immunoglobulin heavy and light chains in the absence of the VH domain.
Levo Y; Recht B; Michaelsen T; Franklin EC; Frangione B
J Immunol; 1977 Aug; 119(2):635-40. PubMed ID: 407302
[TBL] [Abstract][Full Text] [Related]
12. Structure of abnormal heavy chains in human heavy-chain-deposition disease.
Khamlichi AA; Aucouturier P; Preud'homme JL; Cogné M
Eur J Biochem; 1995 Apr; 229(1):54-60. PubMed ID: 7744049
[TBL] [Abstract][Full Text] [Related]
13. [Immunochemical properties of free mu-chain protein in a patient with mu-heavy chain disease].
Tamura A; Yamashiro A; Mizutani F; Oita T; Maeda A; Takahashi T
Rinsho Byori; 2003 Sep; 51(9):847-51. PubMed ID: 14560651
[TBL] [Abstract][Full Text] [Related]
14. Exon skipping without splice site mutation accounting for abnormal immunoglobulin chains in nonsecretory human myeloma.
Cogné M; Guglielmi P
Eur J Immunol; 1993 Jun; 23(6):1289-93. PubMed ID: 8500524
[TBL] [Abstract][Full Text] [Related]
15. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
[TBL] [Abstract][Full Text] [Related]
16. Allelic exclusion in transgenic mice expressing a heavy chain disease-like human mu protein.
Corcos D; Iglesias A; Dunda O; Bucchini D; Jami J
Eur J Immunol; 1991 Nov; 21(11):2711-6. PubMed ID: 1936120
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of the cell-surface expression of immunoglobulin mu chain without light chain in human B lymphocytes.
Pollok BA; Anker R; Eldridge P; Hendershot L; Levitt D
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9199-203. PubMed ID: 3122216
[TBL] [Abstract][Full Text] [Related]
18. [Cloning of Ig Fab genes of patients with chronic B lymphocytic leukemia and sequences analysis of their variable regions].
Zhu H; Wang F; Zhang Y; Shen G
Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):474-9. PubMed ID: 12482359
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin light chain transcripts with altered V regions in Burkitt's lymphoma cell lines producing short mu chains.
Cogné M; Mounir S; Aucouturier P; Preud'homme JL; Nau F; Guglielmi P
Eur J Immunol; 1990 Sep; 20(9):1905-10. PubMed ID: 2120068
[TBL] [Abstract][Full Text] [Related]
20. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
